• N/A
    Market Cap
  • 4.48%
    1-Year Change
  • Shell Companies
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 69
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$10.59
$10.61
$10.60
1-Year Range
$10.15
$10.61
$10.60
Latest Close$10.60
Change
$0.00 (0.00%)
Volume648
Shares Outstanding24.3M
P/E (TTM)40.36
Diluted EPS (TTM)$0.26

Information as of 06/02/2026

Company Profile

DRUGS MADE IN AMERICA ACQUISITION CORP
https://dmaacorp.com
N/A
Market Cap
$6.0M
Net Income
Sector: Financial Services
Industry: Shell Companies
420 Lexington Avenue, New York, NY, United States, 10170
646 726 7074

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Key Executives

  • Roger Bendelac
  • Saleem Elmasri

Current Ownership Distribution

  • Institutions107.6M (80.17%)
  • Mutual Funds17.8M (13.29%)
  • Insiders8.8M (6.54%)
  • Other0 (0.00%)